Spring Liu, Managing Director
Spring is a PhD candidate in Biomedical Engineering at Boston University. Her research focuses on visual information processing, neural encoding/decoding, and mathematical modeling of neural systems. She received her Bachelor’s degree in Biomedical Engineering from Beijing University of Technology with research experience in drug discovery. She became interested in the business side of science after taking the “Bench to Bedside” course with MBA students at the school of management. She joined the HCEP student group in 2009 and has worked on a wide range of consulting projects with multiple biotech start-up clients since then. She is eager to leverage her knowledge, experience and skills for a career in the healthcare consulting industry.
Kinneri Shah, Managing Director
Kinneri is a second year MBA student concentrating in Health Sector Management, Strategy and Corporate Finance at Boston University’s Graduate School of Management. She holds a Bachelors degree in Bioengineering from the University of California, San Diego. She has over 5 years of experience working across R&D, Marketing and Commercial Strategy roles within the Life Science industry and has completed several independent business consulting projects in the field. Upon graduation from the MBA program, Kinneri hopes to pursue a career where she can directly contribute to the commercialization of innovative life enhancing technologies.
Terence Ta, Marketing Manager
Terence Ta graduated from the Massachusetts Institute of Technology with a B.S. in Chemical Engineering and a minor in Biomedical Engineering. He got his start in research at MIT where he worked with Dr. Robert Langer in developing polymeric nanoparticles for the transdermal delivery of wound-healing agents. After graduating from MIT, he entered the Ph.D. program in Biomedical Engineering at Boston University, where he broadened his experience in nanomedicine and drug delivery with projects ranging from the development of vaccine carriers used with a novel pulse-field delivery system, to designing synthetic analogs for cartilage regeneration applications. He is currently a Ph.D. candidate under Dr. Tyrone Porter in the Medical Acoustics Laboratory at BU, where his research focuses on the design of pH/temperature-sensitive liposomes for the targeted delivery of chemotherapeutic drugs, and in the application of focused ultrasound as a minimally invasive source for thermally triggering drug release from these carriers. Outside of research, he has worked at Bristol-Myers Squibb’s Biotechnology Technical Services Division, where he specialized in process optimization and implementation of secure data practices.
Anand is a second year MBA student in the Health Sector Management program. Before coming to BU, Anand worked in R&D for two diagnostics startup companies (First Light Biosciences and IQuum) where he developed assays for automated diagnostics platforms. Anand spent the last summer at Analogic where he created a market analysis for a new DNA-based diagnostic product. Anand would like to work in marketing for a life sciences company after graduation. He holds B.S. and M.S. degrees in Biology from Carnegie Mellon University and UMass Medical School.
Jason Yi, Marketing Manager
Jason Yi graduated from UC Berkeley with a B.S. in Chemistry. He started his career in the pharmaceutical arena at Bayer Healthcare. He gained experience in the highly regulated manufacturing and operations side of the business, moving from a bench scientist role to a conformance role. After five years, he broadened his industry perspective by becoming the director of events at a scientific conference company. There he managed the planning and execution of over 20 nationwide conferences as well as the company’s first international conference in Dublin, Ireland. These conferences focused on cutting edge research that spanned a wide range of topics, from cancer drugs and biomarkers to vaccines and protein therapeutics. With an understanding of the drug discovery and development process, Jason entered the Health Sector Management Program at the Boston University School of Management to enhance his understanding of the business side of the industry. Upon graduation, he will pursue a career in boutique healthcare consulting.
|MBA Students||PhD Students||Medical Students|
|Richard Palmer (2010)||Caroline LaManna (2011)||Valmeek “Vick” Kudesia (2008)|
|Will Peterman (2010)||Janet Tse (2010)||Gurmeet Sran (2009)|
|Jesse Sullivan (2010)||Guenwon Kim (MD/ PhD 2014)|
|David Spenciner (2009)|
|Christine Burnitz (2011)|
|Michael S. Koeris (2009)|
Michael Koeris, CEO, Novophage
Michael Koeris, Ph.D. is the founder of the HCEP Start-Up group along with Prof. Richard Egdahl. During his doctoral training, Mike trained under Jim Collins, focusing on network approaches to combat antibiotic-tolerant bacteria with the Howard Hughes Medical Institute in the Biomedical Engineering Department at Boston University. For his undergraduate degree, Mike graduated second in his class with a B.S. and M.S. in Biochemistry from the Free University of Berlin. He was also a recipient of the German Academic Exchange Fellowship at MIT. In addition to his scientific work, Mike previously worked at McKinsey & Company and was an Entrepreneurial Fellow at Flagship Ventures. Currently, Mike is CEO of Novophage, a spin-out from BU and MIT that is developing green solutions to increase energy efficiency in industrial heating/cooling systems.